Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Square Panda India’s educational series ‘Early Learning Matters’ stresses on bolstering foundational learning
- Stock Market Highlights, July 30, 2025: Sensex settles 143 pts higher, Nifty tops 24850; Check gainers, losers | Closing Bell
- Primus Partners released Policy Square Expert Interview Series
- Andhra Pradesh constitutes Data Centre Advisory Council
